Percutaneous pulmonary valve replacement with the self-expandable Venus P-valve (Venus Medtech, Hangzhou, China) has shown satisfactory feasibility and early and midterm outcomes. However, the long-term results are not well described. This is a report of the gross and microscopic findings of an explanted Venus P-valve 78 months after implantation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.athoracsur.2021.01.037 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!